1. Home
  2. SRI vs SGMO Comparison

SRI vs SGMO Comparison

Compare SRI & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.57

Market Cap

161.7M

ML Signal

HOLD

Logo Sangamo Therapeutics Inc.

SGMO

Sangamo Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

141.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
SGMO
Founded
1965
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
141.2M
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
SRI
SGMO
Price
$5.57
$0.38
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$16.00
$5.75
AVG Volume (30 Days)
182.2K
3.8M
Earning Date
06-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
66.89
EPS
N/A
N/A
Revenue
$824,444,000.00
$36,567,000.00
Revenue This Year
$7.42
$4.79
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.46
88.60
52 Week Low
$3.54
$0.35
52 Week High
$9.71
$0.93

Technical Indicators

Market Signals
Indicator
SRI
SGMO
Relative Strength Index (RSI) 26.58 45.32
Support Level $5.58 $0.36
Resistance Level $6.35 $0.56
Average True Range (ATR) 0.42 0.03
MACD -0.31 -0.00
Stochastic Oscillator 4.76 22.61

Price Performance

Historical Comparison
SRI
SGMO

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: